News FDA approves expanded use for GSK's COPD triple therapy GSK is aiming to revive its respiratory drugs franchise
News GSK sells rare disease drugs, including groundbreaking Strim... CEO Walmsley opts to focus on blockbuster medicines
Market Access Verona to take COPD hopeful into phase 3 Verona Pharma is to take lung drug RPL554 into late clinical development after a successful phase 2b trial.
News GSK to pay $13bn for Novartis stake in OTC joint venture GlaxoSmithKline is to buy out Novartis from their over-the-counter joint venture, and may sell its Horlicks business to fund the £9.2 billion ($13bn) acquisition.
News GSK left as sole bidder for Pfizer consumer health unit GSK is left as sole bidder amid speculation that the sale is off.
News GSK's Luke Miels demands new focus, and cost cuts Further details have emerged about GlaxoSmithKline’s attempts to reinvigorate its business under new CEO Emma Walmsley.
News Court sides with EU on decision to revoke Ocaliva's license Advanz Pharma's bid to keep its Ocaliva treatment for rare liver disease primary biliary cholangitis (PBC) on the EU market has ended in failure
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
